Literature DB >> 20476873

Pneumonia during pregnancy: radiological characteristics, predisposing factors and pregnancy outcomes.

Vitaliy Romanyuk1, Lior Raichel, Ruslan Sergienko, Eyal Sheiner.   

Abstract

UNLABELLED: To establish radiological characteristics of pneumonia during pregnancy and to investigate pregnancy outcomes in patients hospitalised due to pneumonia. STUDY
DESIGN: A population-based study comparing all pregnancies of women with and without pneumonia between was conducted. The diagnosis of pneumonia was confirmed by chest radiograph. Multivariable logistic regression models were constructed in order to control for confounders.
RESULTS: During the study period, there were 181,765 deliveries, of which 160 were hospitalised due to pneumonia. The most common site of pneumonia was the left lower lobe (53.4%), followed by the right lower lobe (26.3%) and right middle lobe (8.3%); 9.8% were complicated with pleural effusion. Using a multivariable analysis, pneumonia was significantly associated with placental abruption (OR = 4.2; 95% CI 1.9-9.1), intrauterine growth restriction (IUGR; OR = 3.7; 95% CI 2.1-6.6), previous caesarean deliveries (CDs; OR = 2.6; 95% CI 1.8-3.7) and severe preeclampsia (OR = 2.6; 95% CI 1.2-5.7). Higher rates of low Apgar scores at 1 min (26.3% vs. 5.9%, <50.001) and 5 min (10.6% vs. 2.6%, p < 0.001) were noted in the pneumonia group. No significant differences were noted between the groups regarding labour induction (23.8% vs. 27.9%, p = 0.240), non-progressive labour second stage (2.5% vs. 1.6%, p = 0.387) and post-partum haemorrhage (1.3% vs. 0.5%, p = 0.224). Furthermore, patients with pneumonia were significantly associated with preterm delivery (PTD,537 weeks) (35.6% vs. 7.7%, p50.001) and perinatal mortality (7.5% vs. 1.3%, p50.001). Pneumonia was found as an independent risk factor for PTD (OR = 5.4, 95% CI 3.8-7.7, p < 0.001), in a multivariable model controlling for IUGR, placental abruption and preeclampsia Controlling for possible confounding variables such as IUGR, gestational age at delivery, placental abruption and maternal age, using another multivariable model with perinatal mortality as the outcome variable, pneumonia was not identified as an independent risk factor for perinatal mortality (weighted OR = 0.9; 95% CI 0.4-1.9; p = 0.718).
CONCLUSION: Maternal pneumonia is associated with adverse perinatal outcomes and specifically it is an independent risk factor for PTD.

Entities:  

Mesh:

Year:  2010        PMID: 20476873     DOI: 10.3109/14767051003678275

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

1.  Unilateral presentation of postpartum cardiomyopathy misdiagnosed as pneumonia.

Authors:  Ben Hayman Amit; Alon Marmor; Amer Hussein
Journal:  BMJ Case Rep       Date:  2010-12-20

Review 2.  Characteristics and pregnancy outcomes of patients with severe pneumonia complicating pregnancy: a retrospective study of 12 cases and a literature review.

Authors:  Pingping Tang; Jiangshan Wang; Yingna Song
Journal:  BMC Pregnancy Childbirth       Date:  2018-11-03       Impact factor: 3.007

3.  Pneumonia and pregnancy outcomes: a nationwide population-based study.

Authors:  Yi-Hua Chen; Joseph Keller; I-Te Wang; Ching-Chun Lin; Herng-Ching Lin
Journal:  Am J Obstet Gynecol       Date:  2012-08-17       Impact factor: 8.661

4.  Seasonal variations in the occurrence of preeclampsia and potential implication of upper respiratory infections in South Korea.

Authors:  Eui Hyeok Kim; Sang Ah Lee; Seunggi Min; Yong Wook Jung
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

5.  Does an upper respiratory tract infection during pregnancy affect perinatal outcomes? A literature review.

Authors:  Julia Harris; Eyal Sheiner
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 6.  Pregnancy and COVID-19: management and challenges.

Authors:  Yao Wenling; Qiu Junchao; Zhirong Xiao; Shi Ouyang
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-08-31       Impact factor: 1.846

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.